The global corticosteroids market is estimated to grow at a significant CAGR during the forecast period. The major factors contributing to the market growth include the rising incidences of chronic diseases and increasing demand for inhaled and topical corticosteroids. The incidence of chronic diseases, such as acute respiratory diseases and rheumatic disorders, is on the rise. Asthma, chronic obstructive pulmonary disease (COPD), pulmonary hypertension, and occupational lung disorders are the most frequent chronic respiratory diseases. As per the WHO, Asthma affected an estimated 262 million people globally in 2019 and caused 4,61,000 deaths.
A full report of Corticosteroids Market is available at: https://www.omrglobal.com/industry-reports/corticosteroids-market-size
COPD is expected to rise in the future, owing to the high incidence of smoking and the aging populations in many countries. Asthma and COPD are becoming more common, which has increased the demand for inhaled corticosteroids to treat them. These are anti-inflammatory medications that are often used as long-term asthma control medication. These medications help in reducing swelling and constriction in the lung airways. Some inhaled corticosteroids that are used for the treatment of asthma include Ciclesonide (Alvesco), Fluticasone (Flovent HFA), Beclomethasone (Qvar RediHaler), Budesonide (Pulmicort Flexhaler), and Mometasone (Asmanex Twisthaler). Inhaled corticosteroids don’t usually cause severe side effects.
To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/corticosteroids-market-size
The global corticosteroids market is segmented based on product, route of administration, and application. Based on the product, the market is classified into glucocorticoids and mineralocorticoids. Based on route of administration, the market is classified into topical, inhaled, oral, systemic, and others. Based on application, the market is classified into skin allergies, rheumatology indications, endocrinology, acute respiratory diseases, gastroenterology, and others.
Market Coverage
- The market number available for – 2020-2027
- Base year- 2020
- Forecast period- 2021-2027
- Segment Covered- By Product, By Route of Administration, By Application
- Competitive Landscape: Novartis International AG, Pfizer Inc., Merck & Co., Inc., AstraZeneca plc, and GlaxoSmithKline plc., among others.
Key questions addressed by the report
- What is the market growth rate?
- Which segment and region dominates the market in base year?
- Which segment and region will project fastest growth in the market?
- How COVID-19 impacted the market?
o Recovery Timeline
o Deviation from pre-COVID forecast
o Most affected region and segment
- Who is the leader in the market?
- How players are addressing challenges to sustain growth?
- Where is the investment opportunity?
Corticosteroids Market- Segmentation
By Product
- Glucocorticoids
- Mineralocorticoids
By Route of Administration
- Topical
- Inhaled
- Oral
- Systemic
- Others
By Application
- Skin Allergies
- Rheumatology Indications
- Endocrinology
- Acute Respiratory Diseases
- Gastroenterology
- Others
This release has been published on Global Market Post. Global Market Post is not responsible for any content included in this release.
